ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer

BACKGROUND: Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) are potential tools to minimize the side effects and substantially enhance the therapeutic efficacy of chemotherapy. However, it is challenging to achieve spatially and temporally controllable and accurate drug release...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nanobiotechnology
Main Authors: Yi, Hanxi, Lu, Wangxing, Liu, Fan, Zhang, Guoqing, Xie, Feifan, Liu, Wenjie, Wang, Lei, Zhou, Wenhu, Cheng, Zeneng
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111982/
https://ncbi.nlm.nih.gov/pubmed/33975609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00877-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados